Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
Efficacy of Adding Auricular Acupuncture to Xiao-Feng-San for Treating Atopic Dermatitis Exhibiting Wind-Dampness-Heat Manifestations According to Traditional Medicine: A Multi-Center, Double-Blinded, Randomized, Sham-Controlled Trial
1 other identifier
interventional
156
1 country
2
Brief Summary
This study aims to compare the efficacy of adding auricular acupuncture to Xiao-Feng-San decoction versus Xiao-Feng-San decoction in treating atopic dermatitis. The trial is a multi-center, double-blinded, randomized, sham-controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedStudy Start
First participant enrolled
July 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2025
CompletedMarch 26, 2025
March 1, 2025
8 months
July 1, 2024
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Scoring Atopic Dermatitis (SCORAD) score
The SCORAD index is a tool used to assess atopic dermatitis (AD) severity. It combines objective measures of lesion extent and intensity with subjective evaluations of symptoms like pruritus and sleep loss. Calculated using the formula: A/5 + 7B/2 + C, where A represents lesion extent (0-100 points), B rates six objective symptoms (0-18 points), and C measures subjective symptoms on a 10-cm scale (0-20 points), the total score ranges from 0 to 103 with higher scores indicating more severe AD.
At randomization and weekly throughout the four-week period (Week 0, Week 1, Week 2, Week 3, Week 4)
Secondary Outcomes (4)
Changes in Dermatology Life Quality Index (DLQI) Score
At randomization and weekly throughout the four-week period (Week 0, Week 1, Week 2, Week 3, Week 4)
Change in the Number of Antihistamine Tablets Used
Weekly throughout the four-week period (Week 1, Week 2, Week 3, Week 4)
Changes in Total Serum Immunoglobulin E (IgE) Levels
At randomization and after four weeks (Week 0, Week 4)
Proportion of intervention-related adverse effects (AEs)
Up to four weeks
Study Arms (2)
XFS + AA
EXPERIMENTALAuricular acupuncture in addition to Xiao-Feng-San.
XFS + Sham AA
PLACEBO COMPARATORSham auricular acupuncture in addition to Xiao-Feng-San.
Interventions
Auricular acupuncture is conducted weekly in four weeks using patches (four sessions), each with a square shape and a side length of 10 mm, along with sterilized needles measuring 0.25 x 1.3 mm. The patch with the needle will remain in place for one week.
Sham auricular acupuncture is conducted weekly for four weeks using patches (four sessions), each with a square shape and a side length of 10 mm. The patches will not contain any needles and will remain in place for one week.
Eligibility Criteria
You may qualify if:
- Diagnosed with atopic dermatitis (AD) according to the American Academy of Dermatology guidelines and classified as mild to moderate.
- Classified under Traditional Medicine as exhibiting wind-dampness-heat manifestations and prescribed Xiao-Feng-San decoction.
- Voluntary informed consent.
You may not qualify if:
- Presence of other active skin diseases or skin infections requiring systemic treatment within the past four weeks or that would interfere with the proper assessment of atopic dermatitis lesions.
- Use of systemic therapy for AD, including but not limited to corticosteroids, methotrexate, cyclosporine, azathioprine, phosphodiesterase type 4 (PDE4) inhibitors, interferon-gamma (IFN-γ), and mycophenolate mofetil within the past four weeks.
- Use of targeted biologic treatments within the past five half-lives (if known) or within the past 12 weeks, whichever is longer.
- Use of phototherapy treatment, laser therapy, tanning booth sessions, or extended sun exposure that could affect disease severity or interfere with disease assessments within the past four weeks.
- Use of systemic anti-infectives within the past four weeks.
- Use of herbal medicine within the past 12 weeks.
- Use of topical treatments for AD, including but not limited to topical corticosteroids (TCS), topical calcineurin inhibitors (TCIs), or topical phosphodiesterase-4 (PDE-4) inhibitors within the past one week.
- History of alcohol or substance addiction within the past six months.
- Prior experience with acupuncture.
- Presence of existing injuries or lesions at the auricular acupoints under investigation in this study.
- Concurrent participation in other clinical trials or use of other therapies for AD.
- Pregnancy, lactation, or planning to become pregnant within approximately 12 weeks after the intervention.
- Any history or current conditions that, in the investigator's assessment, would impede the participant's involvement in the study, the adherence to treatment, the evaluation of treatment efficacy, or pose risks to the participant during the study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Medical Center HCMC - Branch no.3
Ho Chi Minh City, 700000, Vietnam
Traditional Medicine Hospital of Ho Chi Minh City
Ho Chi Minh City, 70000, Vietnam
Related Publications (11)
Cai X, Sun X, Liu L, Zhou Y, Hong S, Wang J, Chen J, Zhang M, Wang C, Lin N, Li S, Xu R, Li X. Efficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high-quality randomized placebo-controlled trials. Front Pharmacol. 2022 Sep 27;13:927304. doi: 10.3389/fphar.2022.927304. eCollection 2022.
PMID: 36238577BACKGROUNDTrinh DTT, Bui MMP, Nguyen HT. The effects of auricular acupuncture at lung, shenmen, endocrine, adrenal points on adult eczema: a randomized trial. MedPharmRes 2023;7(1):47-52.
BACKGROUNDPark JG, Lee H, Yeom M, Chae Y, Park HJ, Kim K. Effect of acupuncture treatment in patients with mild to moderate atopic dermatitis: a randomized, participant- and assessor-blind sham-controlled trial. BMC Complement Med Ther. 2021 Apr 29;21(1):132. doi: 10.1186/s12906-021-03306-1.
PMID: 33926433BACKGROUNDTan HY, Lenon GB, Zhang AL, Xue CC. Efficacy of acupuncture in the management of atopic dermatitis: a systematic review. Clin Exp Dermatol. 2015 Oct;40(7):711-5; quiz 715-6. doi: 10.1111/ced.12732. Epub 2015 Aug 24.
PMID: 26299607BACKGROUNDLee HC, Park SY. Preliminary Comparison of the Efficacy and Safety of Needle-Embedding Therapy with Acupuncture for Atopic Dermatitis Patients. Evid Based Complement Alternat Med. 2019 Apr 23;2019:6937942. doi: 10.1155/2019/6937942. eCollection 2019.
PMID: 31178916BACKGROUNDFukuda M, Kawada N, Kawamura H, Abo T. Treatment for atopic dermatitis by acupuncture. Adv Exp Med Biol. 2004;546:229-37. doi: 10.1007/978-1-4757-4820-8_17. No abstract available.
PMID: 15584378BACKGROUNDSur B, Lee B, Yeom M, Hong JH, Kwon S, Kim ST, Lee HS, Park HJ, Lee H, Hahm DH. Bee venom acupuncture alleviates trimellitic anhydride-induced atopic dermatitis-like skin lesions in mice. BMC Complement Altern Med. 2016 Jan 29;16:38. doi: 10.1186/s12906-016-1019-y.
PMID: 26825274BACKGROUNDSeverity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31. doi: 10.1159/000247298.
PMID: 8435513BACKGROUNDFinlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994 May;19(3):210-6. doi: 10.1111/j.1365-2230.1994.tb01167.x.
PMID: 8033378BACKGROUNDCheng HM, Chiang LC, Jan YM, Chen GW, Li TC. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2011;155(2):141-8. doi: 10.1159/000318861. Epub 2010 Dec 22.
PMID: 21196758BACKGROUNDTran NT, Tran AH, Trinh DT. Efficacy of herbal medicine Xiao-Feng-San combined with auricular acupuncture for atopic dermatitis: A randomized controlled trial. Integr Med Res. 2026 Jun;15(2):101256. doi: 10.1016/j.imr.2025.101256. Epub 2025 Sep 23.
PMID: 41104111DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nga Th Tran, MD,MSc
University of Medicine and Pharmacy at Ho Chi Minh City
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 1, 2024
First Posted
July 9, 2024
Study Start
July 15, 2024
Primary Completion
March 23, 2025
Study Completion
March 23, 2025
Last Updated
March 26, 2025
Record last verified: 2025-03